Free distribution camps are among the most visible forms of prosthetic, orthotic and assistive-technology provision in India.
Government agencies, charitable trusts, corporate social responsibility programmes, religious organisations and disability NGOs regularly announce camps at which artificial limbs, calipers, wheelchairs and other devices are assessed, fitted or distributed without charge.
For a person who cannot afford care, lives far from a permanent rehabilitation centre or has never been referred to a qualified clinician, such a camp can be transformative. It may provide the first realistic opportunity to walk, return to school, resume employment or participate more independently in family and community life.
However, a difficult question is increasingly being discussed within India’s professional O&P community:
Are free camps expanding access—or are they unintentionally destroying the market needed to sustain permanent, professionally staffed O&P services?
The honest answer is that they can do either.
A well-designed programme can reach people who would otherwise receive no care, create awareness, generate referrals and strengthen local services. A poorly designed programme can reset the perceived value of professional care to zero, displace paying patients, bypass local clinicians and leave beneficiaries without follow-up once the photographs have been taken and the camp has moved on.
The issue is not whether charitable provision is good or bad. It is whether the model finances complete clinical care or merely distributes devices.
Why free camps remain necessary
India continues to have substantial unmet need for prostheses, orthoses, mobility products and rehabilitation services. Cost is only one barrier. Others include geography, limited awareness, fragmented referral pathways, shortages of qualified professionals and the concentration of specialist services in major cities.
The World Health Organization states that people using prostheses and orthoses require regular access to qualified teams, equipped workshops and connected services such as rehabilitation and diabetic-foot care. It also identifies affordability, workforce shortages and weak integration into health systems as major barriers to access.
In this environment, outreach programmes perform several legitimate functions:
- Identifying people who have never been assessed
- Bringing services closer to rural and underserved communities
- Removing immediate financial barriers
- Connecting beneficiaries with disability documentation and public schemes
- Supporting people whose families cannot finance private treatment
- Creating public awareness about rehabilitation
- Mobilising CSR funding for assistive technology
- Referring patients who require surgery, physiotherapy or medical management
India’s ADIP Scheme explicitly supports the purchase and fitting of aids and appliances through implementing agencies including ALIMCO, national institutes, composite regional centres, district rehabilitation centres, state corporations and eligible NGOs.
The existence of a publicly funded system is therefore not an intrusion into an otherwise purely commercial market. It is part of India’s social responsibility towards people with disabilities who might otherwise remain excluded.
Many camp beneficiaries were never potential customers for a private clinic. If a person has no ability to pay, providing a free device does not take a sale away from the market. It creates access where no functioning market previously existed.
When a free camp begins to distort the market
Problems arise when free provision is poorly targeted or when a programme treats the physical product as the whole service.
A prosthesis is not simply a collection of components. An orthosis is not merely a plastic shell or metal caliper. The real intervention includes assessment, prescription, measurement or shape capture, design, fabrication, fitting, alignment, gait or functional training, review, adjustment, repair and eventual replacement.
When all of this is advertised simply as a “free artificial limb,” the public can understandably conclude that the device itself should have no price.
That perception can affect local private clinics in several ways.
Patients who could pay may delay care
If camps do not apply meaningful eligibility criteria, some people who could afford private treatment may wait for the next free distribution event.
This represents genuine market displacement. The patient has not been newly brought into care; a potential paying case has moved from a permanent provider to a subsidised programme.
The effect becomes particularly significant when repeated camps are conducted in the same urban market without coordination with existing services.
Professional work becomes invisible
A device-counting model places attention on the number of limbs or calipers distributed rather than on the clinical work required to achieve a safe and functional outcome.
This can make the prosthetist or orthotist appear to be a technician handing over a manufactured object rather than a healthcare professional responsible for assessment, prescription, biomechanical design and continuing care.
It also makes it more difficult for private providers to explain why a properly managed case costs more than the apparent price of a component.
Local clinics inherit unfunded follow-up
A beneficiary may return home after a camp and later experience socket discomfort, skin problems, alignment issues, broken straps, growth-related changes or component failure.
If the organising team has left the district, the patient frequently approaches the nearest workshop or private clinic. That provider must then choose between supplying unpaid care and turning away someone in genuine need.
The original programme records a successful distribution, while the local clinic carries the continuing clinical and financial burden.
Device numbers can replace patient outcomes
CSR reporting naturally prefers visible and easily communicated measures: 100 limbs distributed, 300 beneficiaries reached or 500 devices supplied.
These figures are useful, but they do not establish whether the intervention worked.
A prosthesis that is delivered but abandoned is not a successful rehabilitation outcome. Neither is an orthosis that causes pressure, remains unused or becomes unsuitable as a child grows.
Local capacity can be bypassed
Some organisations transport teams and devices into a district without involving local CPOs, hospitals, physiotherapists or rehabilitation providers.
Although this may produce a successful event, it does little to build permanent capacity. It can also weaken local providers by removing case volume while leaving no sustainable service behind.
The central economic question
The commercial impact of a free camp depends on which patients it serves.
A simple test can be applied:
- If the beneficiary genuinely could not obtain care without financial support, the programme expands access.
- If the beneficiary could and would have paid for appropriate local care, the programme may displace the private market.
- If a device is distributed without adequate assessment, training and follow-up, the programme may consume funding without creating either a successful clinical outcome or a sustainable market.
The objective should therefore not be to stop free provision. It should be to ensure that public and charitable money is directed towards people who require assistance while preserving a functioning professional infrastructure.
The hidden importance of the paying patient
Private O&P clinics cannot survive entirely on goodwill.
They must pay qualified staff, rent clinical and workshop space, maintain machinery, hold stock, manage regulatory requirements, replace tools, fund continuing education and provide adjustments that may not generate a separate invoice.
Paying patients help finance this infrastructure. In many clinics, their revenue also indirectly enables providers to reduce charges, extend payment terms or assist difficult cases.
If every straightforward case is diverted into a free programme, the clinic may be left with complex patients who require substantial time but cannot pay. Eventually, the provider reduces staff, lowers quality, stops investing or closes.
The result is not a victory for charitable access. It is the disappearance of the permanent local service that beneficiaries need after the camp.
A healthy O&P system therefore requires both subsidised access and viable providers.
A tiered model for coexistence
India does not need to choose between free camps and private clinics. It needs a more carefully segmented funding model.
Tier 1: Fully funded essential care
People meeting defined socioeconomic and clinical criteria should receive a complete, clinically appropriate service without charge.
The funding should cover more than the device. It should include professional assessment, fabrication, fitting, training, reviews, adjustments and an agreed warranty or maintenance period.
Tier 2: Subsidised care with a co-payment
Patients with limited but not absent ability to pay could receive a subsidy while contributing an affordable amount.
Co-payments can extend programme funding across more beneficiaries while preserving an understanding that professional clinical services carry value.
They must, however, remain genuinely affordable and should never become a barrier to essential care.
Tier 3: Funded standard solution with patient-selected upgrades
A programme could finance a safe and clinically suitable standard device while allowing a patient to pay for optional features or a higher-specification alternative.
This approach requires safeguards. Upgrades must be clinically appropriate, transparently priced and presented without pressure. The standard funded device must remain a credible solution—not a deliberately inferior product designed to force an additional payment.
Tier 4: Fully private specialist care
Patients able to pay can access services differentiated by convenience, clinical specialisation, technology, component selection and continuity of care.
Examples may include specialist scoliosis bracing, advanced diabetic-foot orthoses, sports prostheses, microprocessor components, complex paediatric management, cosmetic restoration and rapid digital fabrication.
The clinical standard should remain consistent across every tier. What changes is the funding source and, where appropriate, the range of optional features—not the beneficiary’s entitlement to safe professional care.
NGOs should consider funding patients, not duplicating every clinic
An NGO does not necessarily need to own the entire service pathway.
In many locations, a stronger model would involve purchasing care from qualified local providers. The NGO or CSR partner can establish eligibility, finance the intervention and monitor outcomes, while an accredited clinic performs the clinical and technical work.
This could operate through:
- Patient vouchers redeemable with approved providers
- Fixed-price clinical packages
- Outcome-based service contracts
- District-level networks of qualified CPOs
- Agreements with hospitals and rehabilitation centres
- Mobile assessment linked to permanent fitting facilities
- Shared repair and maintenance arrangements
- Transparent standard and upgrade options
Such partnerships preserve patient choice, support local employment and leave behind a permanent service relationship.
Where a large central organisation manufactures the device, a local provider could still be contracted and paid for assessment, measurements, fitting, training, review and maintenance.
The camp should be the beginning, not the endpoint
For custom prosthetic and orthotic care, a one-day distribution event is rarely sufficient.
A better pathway would include:
- Community identification and pre-registration
- Medical and functional screening
- Assessment by an appropriately qualified professional
- Prescription and informed patient choice
- Measurement, casting or digital shape capture
- Fabrication and quality control
- Individual fitting and alignment
- Functional training and education
- Scheduled follow-up at defined intervals
- Repair, replacement and escalation routes
WHO’s prosthetics and orthotics standards cover policy, products, personnel and service provision—not products alone. They are intended to support affordable, high-quality systems integrated into wider health services.
This distinction matters. A camp can be an effective entry point, but it should feed into a continuing service pathway.
Local CPOs must be paid for every stage of care
Professional participation should not be treated as a voluntary addition to an otherwise product-focused budget.
Contracts should identify and fund:
- Clinical assessment
- Prescription and documentation
- Casting or scanning
- Design and fabrication
- Trial and definitive fitting
- Static and dynamic alignment
- Gait or functional training
- Patient and caregiver education
- Review appointments
- Repairs and adjustments
- Outcome reporting
Separating these activities makes the true cost of care visible. It also allows NGOs, CSR teams and government purchasers to compare providers on service quality rather than only on the lowest device price.
Better measurements of success
The number of devices handed over should remain a logistical measure, but it should not be the principal measure of impact.
A stronger reporting framework would examine:
- Percentage of assessed patients who receive an appropriate device
- Time from assessment to fitting
- First-fit success
- Device use after 30, 90 and 180 days
- Comfort and skin condition
- Functional mobility
- Repair frequency and turnaround time
- Device abandonment
- Return to education or employment
- Patient satisfaction
- Achievement of individual rehabilitation goals
- Availability of local follow-up
- Replacement planning for children and changing conditions
These measurements are harder than counting boxes, but they reveal whether funding has produced real participation and independence.
How private O&P providers should respond
Private clinics cannot win a price competition against “free.” They should not try.
Their strongest proposition is continuity, responsiveness and clinical specialisation.
Providers can build sustainable services around focused patient pathways such as:
- Clubfoot management
- Scoliosis and spinal deformity
- Diabetic-foot protection
- Limb salvage and post-amputation rehabilitation
- Paediatric gait disorders
- Cerebral palsy
- Sports prosthetics and orthotics
- Cranial remoulding
- Stroke and neurological rehabilitation
- Complex seating and positioning
Strong referral relationships with surgeons, physiatrists, physiotherapists, podiatrists, wound teams, paediatricians and rehabilitation hospitals can make the private clinic part of a clinical network rather than a retail outlet for devices.
Clinics should also consider maintenance plans, transparent package pricing, staged payments, financing arrangements and contracts with employers, insurers, hospitals and CSR programmes.
The private sector’s value is not that it charges money. Its value is that it can offer permanent access, accountability, clinical choice and rapid continuing support.
A shared responsibility
NGOs should recognise that undermining local providers ultimately weakens beneficiary care.
Private clinics should recognise that millions of Indians cannot access services through out-of-pocket payment alone.
Government and CSR purchasers should recognise that the cheapest device is not necessarily the lowest-cost outcome if it is abandoned, repeatedly remade or unsupported.
Manufacturers should support traceability, repair access and appropriate training.
CPOs should defend professional value while remaining open to new funding models that expand access.
Most importantly, beneficiaries should not be forced to choose between a free device with limited follow-up and a professionally managed service they cannot afford.
The real answer
Free O&P distribution camps are not inherently destroying India’s private market. Many serve people who would otherwise remain outside any service system, and their contribution should be recognised.
But free provision becomes harmful when it is poorly targeted, excludes local professionals, values publicity over outcomes or presents the product as a substitute for clinical care.
The future should not be charity versus commerce.
It should be a coordinated system in which government schemes, CSR funding and NGOs finance access; qualified CPOs deliver and manage care; private providers maintain permanent local capacity; and success is measured by long-term use and participation rather than the number of devices distributed.
Free camps and paid services can coexist—but only when both recognise that the sustainable unit of value is not the device.
It is the complete patient journey.
- Department of Empowerment of Persons with Disabilities: ADIP Scheme
- WHO: Prosthetics and Orthotics Services
- WHO Standards for Prosthetics and Orthotics
- Artificial Limbs Manufacturing Corporation of India
- ARJUN Portal for ADIP and RVY Services